The ICD-10 code for CHARGE Syndrome is Q87.1, which falls under the category of "Other specified congenital malformation syndromes affecting multiple systems." In the previous ICD-9 coding system, the code for CHARGE Syndrome was 759.89, classified as "Other specified congenital anomalies." These codes are used for medical billing and documentation purposes to identify and classify specific conditions.
CHARGE syndrome, also known as CHARGE association, is a complex genetic disorder that affects multiple systems in the body. It is characterized by a wide range of congenital anomalies, including coloboma of the eye, heart defects, atresia of the choanae, retardation of growth and/or development, genital and urinary abnormalities, and ear abnormalities and deafness. Due to its diverse manifestations, CHARGE syndrome requires a comprehensive medical approach for diagnosis and management.
In terms of coding, the International Classification of Diseases, 10th Revision (ICD-10) provides a specific code for CHARGE syndrome. The ICD-10 code for CHARGE syndrome is Q87.1. This code falls under Chapter XVII: Congenital malformations, deformations, and chromosomal abnormalities, and more specifically under the category Q80-Q89: Other congenital malformations.
On the other hand, the International Classification of Diseases, 9th Revision (ICD-9) was replaced by ICD-10 in October 2015. Therefore, there is no specific ICD-9 code for CHARGE syndrome. However, in ICD-9, different codes related to the specific manifestations associated with CHARGE syndrome, such as eye abnormalities, heart defects, and hearing loss, could be utilized to describe the individual components of the syndrome.
It is important to note that accurate coding is crucial for proper medical documentation, billing, and research purposes. Healthcare professionals, including medical coders and billers, rely on the ICD-10 code Q87.1 to appropriately identify and classify cases of CHARGE syndrome. This ensures effective communication and understanding among healthcare providers, researchers, and insurance companies, ultimately leading to improved patient care and outcomes.